Inactive Instrument

Endymed Ltd

Equities

ENDY

IL0011010217

Advanced Medical Equipment & Technology

Endymed Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023

May 24, 2023 at 08:32 am EDT

Endymed Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net income was USD 0.685 million compared to USD 0.628 million a year ago. Basic earnings per share from continuing operations was USD 0.05 compared to USD 0.046 a year ago.

Diluted earnings per share from continuing operations was USD 0.05 compared to USD 0.044 a year ago.

Latest news about Endymed Ltd

Endymed Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
Endymed Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 22	CI
Endymed Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-29	CI
Endymed Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-24	CI
Endymed Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Endymed Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-24	CI
Endymed Ltd Receives FDA Approval for Marketing and Sales of its Brand-New Laser Based Hair Removal Device	22-10-20	CI
Endymed Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Endymed Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-15	CI
Endymed Ltd Appoints Bill Scott as US Subsidiary President, Endymed Inc	22-04-06	CI
Endymed Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-09	CI
Endymed Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-25	CI
Endymed Ltd Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-22	CI
Endymed Medical Ltd. announced that it has received $7 million in funding from OHMK Medical Technology Co. Ltd.	14-08-03	CI
Endymed Medical Ltd. announced that it expects to receive $7 million in funding from OHMK Medical Technology Co. Ltd.	14-06-09	CI
Endymed Ltd. Obtains FDA's First Approval of a RF Device for Home Treatment for Wrinkle Reduction	13-08-22	CI
Endymed Medical Ltd. acquired Applisonix, Ltd. (TASE: APLS) in a reverse merger transaction.	12-02-28	CI

Chart Endymed Ltd

Duration

Period

More charts

Company Profile

Endymed Ltd, formerly Applisonix Ltd, is an Israel-based company. The Company operated for two years under the Ma'ayan Technology Incubator Group, an investment group for high technology premature companies. The Company has three wholly-owned subsidiaries, two in Israel and one subsidiary in Hong Kong. The Company, through wholly-owned subsidiary CureLight Medical Ltd, develops, manufactures and markets ultrasound hair removal equipment based on an in-house technology for both professionals and home users. Starting from January 2012, through wholly owned subsidiary EndyMed Medical Ltd, the Company is also engaged in design, development and marketing of aesthetic treatment equipment based on radiofrequency technology, which is a solution for fractional skin resurfacing, wrinkle treatment, skin tightening, scar treatment and body contouring.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+6.59%	183B
INTUITIVE SURGICAL, INC.	+11.26%	133B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
SIEMENS HEALTHINEERS AG	+0.65%	63.06B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B
AGILENT TECHNOLOGIES, INC.	-0.93%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.35B

Other Advanced Medical Equipment & Technology